Back to Journals » Drug Design, Development and Therapy » Volume 9

Brentuximab vedotin for treatment of relapsed or refractory malignant lymphoma: results of a systematic review and meta-analysis of prospective studies

Total article views   HTML views PDF downloads Totals
11,561 Dovepress* 9,903+ 1,948 11,851
PubMed Central* 1,658 681 2,339
Totals 11,561 2,629 14,190
*Since 20 April 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar